HeartBeam ECG Registry
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- HeartBeam, Inc.
- Study ID
- NCT07501299
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Arrhythmia
- Atrial Fibrillation
- Atrial Flutter
- Bradycardia
- Tachycardia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Electrocardiogram (ECG) — DIAGNOSTIC_TESTThe intervention consists of non-invasive ECG recordings obtained using the HeartBeam System. Participants will use the device to capture cardiac electrical activity for assessment of heart rhythm, conduction patterns, and heart rate abnormalities in a clinical setting.
Study Details
The HeartBeam ECG Registry will collect ECG recordings acquired with the HeartBeam System with relevant clinical information in clinical settings.
Key Dates
- Start date
- Mar 31, 2026
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 600 participants (estimated)
Primary Outcome Measure
Creation of a de-identified ECG dataset for future research and regulatory use [ Time Frame: 2 years ]
Central Contacts
- Pooja Chatterjee408-899-4443
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Allegheny Health Network | Pittsburgh | Pennsylvania | 15212 | Joshua Silverstein, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Pittsburgh, PA
By condition
By specialty
By research site
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- The CONFORM Pivotal TrialRecruiting · Conformal Medical, Inc · Birmingham, Alabama